Komori
Pharma Foods International (2929) · FactLower sales, higher operating profit and recovery in net profit

Substantial Revenue Growth and Continued Consolidated Losses

First written in FY2018-Q3. 8 of 26 entries say "Advanced", first in FY2019-Q1. Latest entry: FY2026.

26entries
9years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2024-Q1 – FY2024WorsenedFY2025-H1 – 2026-06-102018: 220182019: 420192020: 320202021: 420212022: 420222023: 320232024: 320242025: 120252026: 22026
Same theme, other companies
Narrowing of operating and ordinary losses after widening amid revenue growthA theme 6 companies write about · 6 as a headwind · 0 as a tailwind

Pharma Foods International moved to the "Worse" side of this theme in 2025.

The whole theme swung hardest in 2025: 3 of 6 companies on the "Worse" side.

2 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026Lower sales, higher operating profit and recovery in net profitAnnual report

    「As a result, net sales for the fiscal year were ¥63,223 million, down 3.1% from the previous fiscal year, operating profit was ¥2,632 million, up 11.2%, ordinary profit was ¥2,440 million, down 4.4%, and net profit attributable to owners of the parent was ¥1,988 million, up 439.1%.」

    Although consolidated net sales and ordinary profit declined, operating profit increased due in part to controls on advertising expenses, while net profit attributable to owners of the parent recovered from ¥368 million to ¥1,988 million.
  2. 2026-06-10WorsenedFinancial results briefing materials

    「Operating profit (217) (1,430) -1,213」

    The cumulative nine-month operating loss widened from ¥217 million in the same period of the previous year to ¥1,430 million. The materials also stated that a return to profitability was expected for the full year.
  3. FY2025-H1WorsenedAnnual report

    「As a result, revenue for the interim consolidated accounting period was ¥29,857 million, down 5.7% year on year; operating profit was ¥623 million, down 59.4%; ordinary profit was ¥645 million, down 58.2%; and interim net profit attributable to owners of the parent was ¥229 million, down 70.1%.」

    Consolidated net sales declined, and operating income, ordinary income and interim net income attributable to owners of the parent also declined substantially year on year.
  4. FY2024Continued revenue decline and earnings recoveryAnnual report

    「As a result, revenue for the fiscal year was ¥62,147 million, down 9.4% year on year; operating profit was ¥5,113 million, up 41.6%; ordinary profit was ¥5,249 million, up 48.2%; and net profit attributable to owners of the parent was ¥3,205 million, up 4.0%.」

    While consolidated net sales fell 9.4% from the previous fiscal year, operating income, ordinary income and net income increased, and earnings recovery continued.
  5. FY2024-Q3Continued revenue decline and earnings recoveryAnnual report

    「As a result, revenue for the cumulative third quarter was ¥47,171 million, down 10.2% year on year; operating profit was ¥3,266 million, up 99.9%; ordinary profit was ¥3,223 million, up 103.7%; and quarterly net profit attributable to owners of the parent was ¥1,856 million, up 73.7%.」

    While revenue declined, operating income, ordinary income and quarterly net income attributable to owners of the parent all increased from the same period of the previous year, and earnings recovery continued.
  6. FY2024-Q2RestatedAnnual report

    「As a result, net sales for the six-month period of the second quarter of the fiscal year under review were ¥31,652 million, down 9.9% year on year, operating income was ¥1,535 million, compared with a loss of ¥883 million in the same period of the previous year, ordinary income was ¥1,542 million, compared with a loss of ¥912 million, and net income attributable to owners of the parent was ¥768 million, compared with a loss of ¥914 million.」

    While consolidated net sales fell 9.9% year on year, operating income, ordinary income and quarterly net income attributable to owners of the parent all continued to remain profitable after turning from losses in the same period of the previous year.
  7. FY2024-Q1Lower Revenue and Return to ProfitabilityAnnual report

    「As a result, net sales for the three-month period of the first quarter of the fiscal year under review were ¥16,142 million, down 5.2% year on year, operating income was ¥601 million, compared with a loss of ¥2,194 million in the same period of the previous year, ordinary income was ¥605 million, compared with a loss of ¥2,180 million, and net income attributable to owners of the parent was ¥286 million, compared with a loss of ¥1,820 million.」

    While net sales fell 5.2% year on year, operating income of ¥601 million, ordinary income of ¥605 million and quarterly net income attributable to owners of the parent of ¥286 million were recorded, turning from losses in the same period of the previous year to profits.
  8. FY2023AdvancedAnnual report

    「As a result, revenue for the fiscal year reached ¥68,572 million, up 13.9% year on year; operating profit was ¥3,610 million, up 234.1%; ordinary profit was ¥3,540 million, up 179.9%; and net profit attributable to owners of the parent was ¥3,081 million, compared with a net loss attributable to owners of the parent of ¥374 million in the previous fiscal year.」

    Consolidated net sales continued to increase, while operating income, ordinary income and bottom-line results all improved from the previous fiscal year, turning from a bottom-line loss to a profit.
  9. FY2023-Q2WorsenedAnnual report

    「As a result, net sales for the six-month period of the second quarter of the fiscal year under review were ¥35,143 million, up 21.9% year on year, operating loss was ¥883 million, compared with income of ¥2,032 million in the same period of the previous year, ordinary loss was ¥912 million, compared with income of ¥2,105 million, and net loss attributable to owners of the parent was ¥914 million, compared with income of ¥1,561 million.」

    While consolidated net sales rose 21.9% year on year, operating, ordinary and income attributable to owners of the parent all turned from profits in the same period of the previous year to losses.
  10. FY2023-Q1WorsenedAnnual report

    「As a result, net sales for the three-month period of the first quarter of the fiscal year under review were ¥17,030 million, up 35.1% year on year, operating loss was ¥2,194 million, compared with income of ¥1,575 million in the same period of the previous year, ordinary loss was ¥2,180 million, compared with income of ¥1,617 million in the same period of the previous year, and net loss attributable to owners of the parent was ¥1,820 million, compared with income of ¥1,231 million.」

    While consolidated net sales increased, operating, ordinary and income attributable to owners of the parent all turned from profits in the same period of the previous year to losses.
  11. FY2022Higher revenue, lower earnings, and a bottom-line lossAnnual report

    「As a result, net sales for the consolidated fiscal year under review were ¥60,185 million, up 28.7% from the previous fiscal year, operating income was ¥1,080 million, down 81.0%, ordinary income was ¥1,264 million, down 78.1%, and net loss attributable to owners of the parent was ¥374 million, compared with income of ¥3,841 million in the previous fiscal year.」

    Revenue growth was maintained, but operating and ordinary income declined substantially, and bottom-line results turned from income to a loss.
  12. FY2022-Q3WorsenedAnnual report

    「As a result, net sales for the nine-month period of the third quarter of the fiscal year under review were ¥44,050 million, compared with ¥33,748 million in the same period of the previous year, an increase of 30.5% year on year. In terms of earnings, operating income was ¥931 million, down 64.6% from ¥2,633 million in the same period of the previous year, ordinary income was ¥1,076 million, down 60.4% from ¥2,716 million, and net loss attributable to owners of the parent was ¥284 million, compared with income of ¥1,553 million.」

    While consolidated net sales increased, operating and ordinary income declined substantially, and the Company turned to a quarterly net loss attributable to owners of the parent.
  13. FY2022-Q2AdvancedAnnual report

    「As a result, net sales for the six-month period of the second quarter of the fiscal year under review were ¥28,821 million, compared with ¥20,393 million in the same period of the previous year, an increase of 41.3% year on year. In terms of earnings, operating income was ¥2,032 million, compared with a loss of ¥81 million in the same period of the previous year, ordinary income was ¥2,105 million, compared with a loss of ¥49 million, and net income attributable to owners of the parent was ¥1,561 million, compared with a loss of ¥446 million.」

    Amid continued substantial revenue growth, operating income, ordinary income and income attributable to owners of the parent turned from losses in the same period of the previous year to profits.
  14. FY2022-Q1Turnaround to consolidated profitabilityAnnual report

    「As a result, revenue for the cumulative first quarter reached ¥12,606 million, compared with ¥8,387 million in the same period a year earlier, up 50.3% year on year. In terms of earnings, operating profit was ¥1,575 million, compared with an operating loss of ¥1,428 million in the same period a year earlier; ordinary profit was ¥1,617 million, compared with an ordinary loss of ¥1,405 million; and net profit attributable to owners of the parent was ¥1,231 million, compared with a net loss of ¥1,427 million.」

    Amid continued substantial revenue growth, operating, ordinary and net income all turned from consolidated losses in the same period of the previous year to profits.
  15. FY2021AdvancedAnnual report

    「As a result, net sales for the consolidated fiscal year under review were ¥46,752 million, up 204.5% from the previous fiscal year, operating income was ¥5,673 million, up 666.6%, ordinary income was ¥5,767 million, up 631.0%, and net income attributable to owners of the parent was ¥3,841 million, up 455.9%, successfully combining proactive investment with profit generation.」

    Consolidated net sales rose 204.5% and operating income was ¥5,673 million, a substantial increase from operating income of ¥740 million in the previous fiscal year.
  16. FY2021-Q3AdvancedAnnual report

    「Net sales for the nine-month period of the third quarter of the fiscal year under review were ¥33,748 million, compared with ¥11,112 million in the same period of the previous year. Driven by sales of hair-growth products and cosmetics, the Group as a whole achieved substantial revenue growth of 203.7% year on year. Operating income was ¥2,633 million, compared with an operating loss of ¥257 million in the same period of the previous year.」

    Consolidated net sales rose 203.7% year on year to ¥33,748 million, while operating results turned from a loss of ¥257 million in the same period of the previous year to income of ¥2,633 million.
  17. FY2021-Q2AdvancedAnnual report

    「Operating loss was ¥81 million, compared with an operating loss of ¥1,585 million in the same period of the previous year. This was because the business model of the Group's direct-to-consumer business has changed to a structure that can generate profits at an early stage without waiting for the full year, while making high levels of advertising and promotional investment.」

    While maintaining substantial revenue growth, operating loss narrowed sharply from ¥1,585 million in the same period of the previous year to ¥81 million. The Company also explained that the direct-to-consumer business had developed a structure for generating profits earlier.
  18. FY2021-Q1WorsenedAnnual report

    「As a result of this proactive investment, net sales for the three-month period of the first quarter of the fiscal year under review rose 2.7-fold to ¥8,387 million, compared with ¥3,090 million in the same period of the previous year, an increase of 171.4% year on year. In terms of earnings, operating loss was ¥1,428 million, compared with a loss of ¥784 million in the same period of the previous year, while ordinary loss was ¥1,405 million, compared with a loss of ¥767 million.」

    While net sales increased substantially, operating and ordinary losses both widened from the same period of the previous year due to the front-loading of advertising investment.
  19. FY2020-Q3Record quarterly profit alongside a cumulative lossAnnual report

    「As a result of these achievements, net sales for the nine-month period of the third quarter of the fiscal year under review rose sharply by 41.2% year on year to ¥11,112 million, compared with ¥7,868 million in the same period of the previous year. Operating income for the third quarter increased to a record ¥1,328 million, indicating the successful generation of earnings through proactive investment.」

    Cumulative net sales rose 41.2% year on year, and operating income for the third quarter reached a record ¥1,328 million, while the cumulative operating loss continued at ¥257 million.
  20. FY2020-Q2WorsenedAnnual report

    「Operating loss was ¥1,585 million, compared with an operating loss of ¥288 million in the same period of the previous year.」

    While consolidated net sales rose 24.4% year on year, operating loss widened from ¥288 million in the same period of the previous year to ¥1,585 million.
  21. FY2020-Q1WorsenedAnnual report

    「In terms of earnings, the company made strategic upfront investments in the mail-order business and recorded ¥2,296 million in advertising expenses, compared with ¥1,734 million in the same period a year earlier. As a result, operating loss was ¥784 million, compared with a loss of ¥391 million in the same period a year earlier; ordinary loss was ¥767 million, compared with a loss of ¥362 million; and net loss attributable to owners of the parent was ¥782 million, compared with a loss of ¥382 million.」

    While consolidated net sales rose 20.0% year on year, operating, ordinary and net losses all widened from the same period of the previous year due to higher advertising and promotional expenses.
  22. FY2019Shift from consolidated losses to profitability and record-high profitAnnual report

    「In the consolidated fiscal year under review, all 3 businesses reported higher revenue and earnings, achieving record highs in net sales, operating income, ordinary income and net income.」

    Having turned around from the continuing consolidated operating loss, all 3 businesses reported higher revenue and earnings and achieved record highs for each profit measure.
  23. FY2019-Q3AdvancedAnnual report

    「In the cumulative third quarter of the current consolidated fiscal year, all 3 businesses performed steadily, with revenue of ¥7,868 million, compared with ¥5,918 million in the same period of the previous year, representing a sharp 32.9% year-on-year increase. In terms of earnings, strategic upfront investment was made in the mail-order business, resulting in advertising expenses of ¥4,314 million (¥3,212 million in the same period of the previous year) and an operating loss of ¥120 million (an operating loss of ¥238 million in the same period of the previous year), an improvement in earnings year on year.」

    Revenue from all 3 businesses increased consolidated revenue by 32.9% year on year, while operating loss narrowed from ¥238 million in the same period of the previous year to ¥120 million.
  24. FY2019-Q2AdvancedAnnual report

    「In the cumulative second quarter of the current consolidated fiscal year, all 3 businesses achieved revenue and profit growth. Revenue was ¥5,188 million, compared with ¥3,673 million in the same period of the previous year, representing a sharp 41.2% year-on-year increase.」

    Revenue and profit growth across all 3 businesses drove a 41.2% year-on-year increase in consolidated revenue. Operating loss also narrowed from ¥862 million in the same period of the previous year to ¥288 million.
  25. FY2019-Q1AdvancedAnnual report

    「As a result, revenue for the cumulative first quarter of the current consolidated fiscal year was ¥2,575 million, compared with ¥1,613 million in the same period of the previous year, representing a sharp 59.6% year-on-year increase. In terms of earnings, strategic upfront investment was made in the mail-order business, resulting in advertising expenses of ¥1,734 million (¥1,209 million in the same period of the previous year) and an operating loss of ¥391 million (a loss of ¥483 million in the same period of the previous year).」

    While sharp revenue growth continued, operating loss narrowed from ¥483 million in the same period of the previous year to ¥391 million, indicating a numerical improvement in consolidated losses.
  26. FY2018-Q3First statedAnnual report

    「For the cumulative third quarter of the current consolidated fiscal year, revenue was ¥5,918 million, up 74.0% year on year; operating loss was ¥238 million (a loss of ¥193 million in the same period of the previous year); ordinary loss was ¥194 million (a loss of ¥152 million in the same period of the previous year); and net loss attributable to owners of the parent was ¥194 million (a loss of ¥181 million in the same period of the previous year).」

    Consolidated revenue increased sharply, by 74.0% year on year, while operating loss, ordinary loss and quarterly net loss attributable to owners of the parent continued, with each loss exceeding the level recorded in the same period of the previous year.
Moved together

"Rapid Growth of the Mail-Order Business and the Burden of Upfront Investment" moved the same way as this thread, in the same document, in 11 of its 26 moves.

111010877★123456
  1. ★This thread
  2. 1Rapid Growth of the Mail-Order Business and the Burden of Upfront Investment11×
  3. 2Revenue Growth and Return to Profitability in the Mail-Order Business10×
  4. 3Higher revenue and narrower loss in the biomedical business10×
  5. 4 적극ive efforts under the Foods with Function Claims system8×
  6. 5Decline in Cash and Cash Equivalents7×
  7. 6Functional Materials business: lower revenue and profit7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Pharma Foods International yet. It last moved in the Financial results briefing materials of 2026-06-10: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.